Lynelle Hoch is President, Cell Therapy Org. of BRISTOL MYERS SQUIBB CO. Currently has a direct ownership of 1,726 shares of BMY, which is worth approximately $96,259. The most recent transaction as insider was on Mar 10, 2024, when has been sold 1,308 shares (Common Stock, $0.10 par value) at a price of $53.79 per share, resulting in proceeds of $70,357. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.73K
0% 3M change
n/a 12M change
Total Value Held $96,259

Lynelle Hoch Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 10 2024
SELL
Payment of exercise price or tax liability
$70,357 $53.79 p/Share
1,308 Reduced 43.11%
1,726 Common Stock, $0.10 pa...
Mar 10 2024
SELL
Other acquisition or disposition
-
1,317 Reduced 33.26%
2,643 Common Stock, $0.10 pa...
Mar 10 2024
BUY
Exercise of conversion of derivative security
-
4,351 Added 53.5%
3,781 Common Stock, $0.10 pa...
LH

Lynelle Hoch

President, Cell Therapy Org.
Princeton, NJ

Track Institutional and Insider Activities on BMY

Follow BRISTOL MYERS SQUIBB CO and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BMY shares.

Notify only if

Insider Trading

Get notified when an Bristol Myers Squibb CO insider buys or sells BMY shares.

Notify only if

News

Receive news related to BRISTOL MYERS SQUIBB CO

Track Activities on BMY